Status:
ACTIVE_NOT_RECRUITING
Efficacy of Combined Interferential Therapy and Electronic Cupping Therapy for Chronic Constipation Management
Lead Sponsor:
Middle East University
Conditions:
Constipation
Eligibility:
All Genders
20-40 years
Phase:
NA
Brief Summary
Constipation is a common gastrointestinal issue affecting individuals worldwide. Interferential therapy, a form of electrotherapy, has been suggested to have potential benefits in improving gastrointe...
Detailed Description
Objective: The purpose of this study was to assess the effectiveness of a combined treatment regimen that includes interferential therapy and electronic cupping therapy on the symptoms of chronic cons...
Eligibility Criteria
Inclusion
- history of Chronic Constipation (CC), as defined by either experiencing two or fewer Complete Spontaneous Bowel Movements (CSBMs) per week for a minimum of 6 consecutive months before the screening visit
- Reporting a sensation of incomplete evacuation or straining during at least a quarter of their bowel movements (according to the generally accepted definition of constipation).
- Patients must have had CC persisting for more than 6 months, failed to respond to or be intolerant of medical treatment for at least 3 months
Exclusion
- pregnant or lactating women
- Chronic Constipation (CC) resulting from anorectal malformations such as colorectal or anal organic lesions, pelvic floor disorders requiring surgical intervention as determined by the investigator (such as rectal prolapse, rectocele, or enterocele)
- presence of implanted electronic devices like cardiac pacemakers, defibrillators, cardiac pumps, or spinal stimulators
- CC attributable to medications or neurologic, endocrine, or metabolic conditions
- prior history of partial colectomy; conditions like megacolon, megarectum, or colonic inertia
- skin abnormalities that hinder the placement of electrodes
- women lacking adequate contraception (hormonal or intrauterine device).
Key Trial Info
Start Date :
February 14 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2024
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT06611852
Start Date
February 14 2023
End Date
November 30 2024
Last Update
September 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
October 6 university
October City, Giza Governorate, Egypt, 6892